Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monocyte differentiation antigen CD14 is an essential pattern recognition receptor predominantly found on myeloid cells. It detects bacterial components—especially LPS—and initiates innate immune responses through cooperation with TLR4. Its unique GPI-anchor distinguishes it structurally from many other membrane receptors. Both its membrane-bound and soluble forms are functionally significant for host defense against infection.
CD14 acts as a co-receptor with TLR4 and MD2 to detect LPS and other PAMPs, triggering intracellular signaling cascades and proinflammatory cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monocyte differentiation antigen CD14 (CD14).